Advertisement
Journal Home
Search for

Volume 81, Issue 3, Pages 261-264 (March 2010)


View previous. 17 of 18 View next.

In vitro Actinomyces israelii biofilm development on IUD copper surfaces

Mónica CarrilloaCorresponding Author Informationemail address, Benjamín Valdezb, Lidia Vargasb, Lydia Alvarezb, Miguel Schorrb, Roumen Zlatevc, Margarita Stoytchevac

Received 20 January 2009; received in revised form 17 September 2009; accepted 18 September 2009. published online 30 October 2009.

Abstract 

Background

Female pelvic actinomycosis may involve fallopian tubes, ovaries, uterus and bladder. This condition is often associated with the use of intrauterine contraceptive devices (IUDs), vaginal pessaries and/or tampons. The predominant causative agent of human actinomycosis is Actinomyces israelii, which has been found on copper IUDs retrieved from patients.

Study Design

In this work, a biofilm of A. israelii was developed in vitro on copper surfaces immersed in a simulated uterine fluid under anaerobic conditions. The biofilm was characterized using scanning electron microscopy (SEM), energy dispersive X-ray and atomic force microscopy.

Results

The capacity of A. israelii to develop a biofilm over copper surfaces in synthetic media was demonstrated. SEM micrographies illustrate the exopolysaccharides production and bacterial distribution.

Conclusion

A. israelii was able to attach and grow in synthetic intrauterine media and to present on the copper surface is likely due to the production of biofilm.

a Laboratory of Industrial Microbiology and Biofilms, Engineering Institute, Universidad Autonoma de Baja California, 21280 Mexicali, Baja California, Mexico

b Laboratory of Materials, Engineering Institute, Universidad Autonoma de Baja California, 21280 Mexicali, Baja California, Mexico

c Laboratory of Electrochemistry, Engineering Institute, Universidad Autonoma de Baja California, 21280 Mexicali, Baja California, Mexico

Corresponding Author InformationCorresponding author. Tel.: +52 686 566 4150; fax: +52 686 566 4150.

PII: S0010-7824(09)00418-1

doi:10.1016/j.contraception.2009.09.008


View previous. 17 of 18 View next.

Advertisement